• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Comprehensive Overview of Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate (CAS No. 2438941-82-1)

Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate is a specialized organic compound with the CAS registry number 2438941-82-1. This compound belongs to the pyrazolo[1,5-a]pyridine family, a class of heterocyclic compounds that have garnered significant attention in pharmaceutical and agrochemical research due to their versatile biological activities. The oxalate salt form enhances its stability and solubility, making it a preferred choice for various applications in drug discovery and development.

The structural uniqueness of Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate lies in its fused bicyclic system, which combines a pyrazole and pyridine ring. This architecture is often associated with improved binding affinity to biological targets, particularly in the context of kinase inhibition and receptor modulation. Researchers are increasingly exploring its potential in designing novel therapeutics for conditions such as inflammation, metabolic disorders, and certain types of cancers. The compound's CAS No. 2438941-82-1 serves as a critical identifier in global chemical databases, ensuring accurate referencing in scientific literature.

In recent years, the demand for pyrazolo[1,5-a]pyridine derivatives has surged, driven by their role in fragment-based drug design and high-throughput screening. The methanamine moiety in this compound further expands its utility, enabling facile derivatization for structure-activity relationship (SAR) studies. Its oxalate salt form is particularly valued for its crystalline properties, which facilitate characterization and formulation processes. These attributes make Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate a compelling candidate for medicinal chemistry projects.

From a synthetic chemistry perspective, the preparation of Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate involves multi-step organic transformations, often starting from commercially available pyridine or pyrazole precursors. Key steps may include cyclization, functional group interconversion, and salt formation. The oxalate counterion is typically introduced in the final step to improve the compound's physicochemical properties. Researchers emphasize the importance of optimizing reaction conditions to achieve high yields and purity, as impurities can significantly impact biological assay results.

The compound's relevance extends beyond pharmaceuticals. In material science, pyrazolo[1,5-a]pyridine scaffolds are investigated for their optoelectronic properties, potentially contributing to advancements in organic light-emitting diodes (OLEDs) and photovoltaic devices. The methanamine group's nucleophilic character also opens doors for polymer functionalization, enabling the development of novel polymeric materials with tailored properties. This interdisciplinary appeal underscores the versatility of CAS No. 2438941-82-1.

Quality control and analytical characterization are paramount when working with Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate. Techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS) are routinely employed to verify identity and purity. Regulatory compliance, particularly in pharmaceutical applications, necessitates rigorous documentation of synthetic routes, impurity profiles, and stability data. These practices ensure reproducibility and safety in downstream applications.

Emerging trends in green chemistry have also influenced the synthesis and use of pyrazolo[1,5-a]pyridine derivatives. Researchers are exploring catalytic methods and solvent-free reactions to minimize environmental impact while maintaining efficiency. The oxalate salt of Pyrazolo[1,5-a]pyridin-7-ylmethanamine aligns with these initiatives, as oxalic acid is a naturally occurring dicarboxylic acid, offering a relatively benign counterion compared to traditional alternatives.

In summary, Pyrazolo[1,5-a]pyridin-7-ylmethanamine oxalate (CAS No. 2438941-82-1) represents a multifaceted compound with broad applicability in life sciences and materials engineering. Its structural features, combined with the practical advantages of the oxalate salt form, position it as a valuable tool for researchers tackling diverse scientific challenges. As interest in heterocyclic chemistry continues to grow, this compound is poised to play a pivotal role in innovation across multiple disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)